A biotech consultant has been charged by the SEC with two counts of insider trading charges, with federal prosecutors and securities regulators claiming the defendant made profitable stock trades using confidential information he learned during his time consulting for Abeona Therapeutics. The U.S. attorney’s office in Massachusetts and the Securities and Exchange Commission (SEC)...